Author

A. Angelillo-Scherrer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:mouse· 1

Frequent Co-Authors

N. Andina· 2 shared N. Bonadies· 2 shared R. Allam· 2 shared A. Gazdhar· 1 shared A. S. Schnegg-Kaufmann· 1 shared A. Tardivel· 1 shared C. Ansermet· 1 shared C. Hirzel· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

N. Andina

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJan 27, 2022

Heightened NLRP3 inflammasome activation is associated with aging and CMML diseases severity

N. Andina, L. de Meuron, A. S. Schnegg-Kaufmann…·R. Allam

This study shows that aging increases NLRP3 inflammasome sensitivity in monocytes, linking it to inflammation and CMML disease severity.

DOI 10.1101/2022.01.27.477992

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintApr 12, 2021

LRR protein RNH1 dampens the inflammasome activation and is associated with adverse clinical outcomes in COVID-19 patients

G. Bombaci, M. A. Sarangdhar, N. Andina…·R. Allam

This study identifies RNH1 as an inhibitor of inflammasome activation, showing its protective role in limiting inflammation and its association with worse outcomes in COVID-19.

DOI 10.1101/2021.04.12.438219

𝕏 PostBluesky